Position in BSX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,369,814
-$593,884 QoQ
Shares Held
32,095
+2.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#634
of 1,468 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $34,102,577 across 41 Medical Devices names. BSX ranks #7 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
68,541 | $5,361,962 | |
| 2 | NPCE |
NeuroPace Inc
|
115,535 | $1,835,851 | |
| 3 | QTRX |
Quanterix Corp
|
410,252 | $1,772,288 | |
| 4 | PODD |
Insulet Corp
|
11,310 | $1,721,947 | |
| 5 | INFU |
InfuSystem Holdings, Inc
|
160,439 | $1,548,236 | |
| 6 | VMD |
Viemed Healthcare, Inc.
|
127,591 | $1,454,537 | |
| 7 | BSX |
Boston Scientific Corp
This page
|
32,095 | $1,369,814 | |
| 8 | DXCM |
Dexcom Inc
|
19,820 | $1,334,877 |
All Filings in BSX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,369,814 | 32,095 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,963,698 | 31,294 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $975,621 | 10,232 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,858,387 | 19,035 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $359,608 | 3,348 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $416,432 | 4,128 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $294,666 | 3,299 | Shares | Sole | 2025-02-07 | |
| 2022-06-30 | $714,913 | 19,182 | Shares | Sole | 2022-08-09 | |
| 2020-09-30 | $287,759 | 7,531 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $269,469 | 7,675 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||